CN111315886A - 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物 - Google Patents

重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物 Download PDF

Info

Publication number
CN111315886A
CN111315886A CN201780092441.0A CN201780092441A CN111315886A CN 111315886 A CN111315886 A CN 111315886A CN 201780092441 A CN201780092441 A CN 201780092441A CN 111315886 A CN111315886 A CN 111315886A
Authority
CN
China
Prior art keywords
pharmaceutical composition
bfgf
seq
fibroblast growth
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780092441.0A
Other languages
English (en)
Inventor
方海洲
戴佩旻
杨波
王新志
王振恒
严贤龙
薛琦
熊璎珞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuhai Essex Bio Pharmaceutical Co ltd
Original Assignee
Zhuhai Essex Bio Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhuhai Essex Bio Pharmaceutical Co ltd filed Critical Zhuhai Essex Bio Pharmaceutical Co ltd
Publication of CN111315886A publication Critical patent/CN111315886A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

提供了一种重组人碱性成纤维细胞生长因子（rh‑bFGF）的突变核酸分子，和所述rh‑bFGF的药物组合物及其用途。

Description

PCT国内申请，说明书已公开。

Claims (17)

  1. PCT国内申请，权利要求书已公开。
CN201780092441.0A 2017-06-23 2017-06-23 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物 Pending CN111315886A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2017/089823 WO2018232750A1 (zh) 2017-06-23 2017-06-23 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物

Publications (1)

Publication Number Publication Date
CN111315886A true CN111315886A (zh) 2020-06-19

Family

ID=64735425

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780092441.0A Pending CN111315886A (zh) 2017-06-23 2017-06-23 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物

Country Status (8)

Country Link
US (1) US11254723B2 (zh)
EP (1) EP3643784A4 (zh)
JP (1) JP7044870B2 (zh)
KR (1) KR102480402B1 (zh)
CN (1) CN111315886A (zh)
MY (1) MY194351A (zh)
SG (1) SG11201912799SA (zh)
WO (1) WO2018232750A1 (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113274486A (zh) * 2021-04-15 2021-08-20 上海腾瑞制药股份有限公司 一种稳定的酸性成纤维细胞生长因子制剂及其制备方法和应用
CN116392441A (zh) * 2023-04-21 2023-07-07 上海腾瑞制药股份有限公司 一种酸性成纤维细胞生长因子滴眼液制剂
CN116889545A (zh) * 2023-06-27 2023-10-17 上海腾瑞制药股份有限公司 一种重组人酸性成纤维细胞生长因子凝胶剂及其制备工艺

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111647089A (zh) * 2020-06-30 2020-09-11 安徽九川生物科技有限公司 一种重组类人弹性蛋白及其组合物
TW202233225A (zh) * 2020-11-16 2022-09-01 雅祥生技醫藥股份有限公司 穩定的酸性纖維母細胞生長因子組合物
CN117447580B (zh) * 2023-12-18 2024-04-30 朗肽生物制药股份有限公司 一种碱性成纤维细胞生长因子改构蛋白在护肤产品中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1448510A (zh) * 2002-04-04 2003-10-15 北京三元基因工程有限公司 一种重组人碱性成纤维细胞生长因子的高效表达
CN101947309A (zh) * 2010-04-12 2011-01-19 南海朗肽制药有限公司 人碱性成纤维细胞生长因子滴眼液及其制备方法
CN103667329A (zh) * 2012-09-17 2014-03-26 北京双鹭药业股份有限公司 一种高效制备重组人碱性成纤维细胞生长因子的方法
CN104606666A (zh) * 2015-02-12 2015-05-13 珠海亿胜生物制药有限公司 重组牛碱性成纤维细胞生长因子滴眼液
CN104984326A (zh) * 2015-07-14 2015-10-21 珠海亿胜生物制药有限公司 不含抑菌剂的重组人碱性成纤维细胞生长因子凝胶剂及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01291797A (ja) * 1987-06-26 1989-11-24 Progen Biotechnik Gmbh 成長因子をコードする合成遺伝子
KR100484653B1 (ko) * 2004-05-06 2005-04-20 주식회사 대웅 원핵세포에서 활성형의 가용성 단백질을 제조하는 방법 및 이를 위한 폴리시스트론 벡터
CN1634567A (zh) * 2004-09-28 2005-07-06 广州暨南大学医药生物技术研究开发中心 一种含有碱性成纤维生长因子凝胶剂的制备工艺及配方
CN1733294A (zh) 2005-08-10 2006-02-15 南海朗肽制药有限公司 一种重组人碱性成纤维细胞生长因子凝胶剂及其制备方法
US20070185014A1 (en) * 2006-02-09 2007-08-09 The Schepens Eye Research Institute, Inc. Methods and compositions for modulating conjunctival goblet cells
WO2011010399A1 (ja) * 2009-07-24 2011-01-27 千寿製薬株式会社 角膜内皮細胞増殖促進剤
CN101658491B (zh) * 2009-09-24 2011-04-13 哈尔滨医科大学 一种治疗角膜碱烧伤的羊膜滴眼液
US20110300097A1 (en) * 2010-06-04 2011-12-08 Al-Qahtani Ahmed H Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca
CN102389392B (zh) * 2011-11-02 2012-10-24 珠海亿胜生物制药有限公司 重组牛碱性成纤维细胞生长因子眼用凝胶
GB2510407A (en) * 2013-02-04 2014-08-06 Kalvista Pharmaceuticals Ltd Aqueous suspensions of kallikrein inhibitors for parenteral administration
JP2016521175A (ja) * 2013-05-08 2016-07-21 オプトメトリック テクノロジー グループ リミテッド 眼の健康管理用具および方法
CN106038350A (zh) * 2016-05-31 2016-10-26 南海朗肽制药有限公司 一种复合生长因子护肤凝胶及其制备方法
CN107320716B (zh) * 2017-06-27 2019-03-05 珠海亿胜生物制药有限公司 碱性成纤维细胞生长因子囊泡及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1448510A (zh) * 2002-04-04 2003-10-15 北京三元基因工程有限公司 一种重组人碱性成纤维细胞生长因子的高效表达
CN101947309A (zh) * 2010-04-12 2011-01-19 南海朗肽制药有限公司 人碱性成纤维细胞生长因子滴眼液及其制备方法
CN103667329A (zh) * 2012-09-17 2014-03-26 北京双鹭药业股份有限公司 一种高效制备重组人碱性成纤维细胞生长因子的方法
CN104606666A (zh) * 2015-02-12 2015-05-13 珠海亿胜生物制药有限公司 重组牛碱性成纤维细胞生长因子滴眼液
CN104984326A (zh) * 2015-07-14 2015-10-21 珠海亿胜生物制药有限公司 不含抑菌剂的重组人碱性成纤维细胞生长因子凝胶剂及其制备方法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113274486A (zh) * 2021-04-15 2021-08-20 上海腾瑞制药股份有限公司 一种稳定的酸性成纤维细胞生长因子制剂及其制备方法和应用
CN116392441A (zh) * 2023-04-21 2023-07-07 上海腾瑞制药股份有限公司 一种酸性成纤维细胞生长因子滴眼液制剂
CN116392441B (zh) * 2023-04-21 2023-11-28 上海腾瑞制药股份有限公司 一种酸性成纤维细胞生长因子滴眼液制剂
CN116889545A (zh) * 2023-06-27 2023-10-17 上海腾瑞制药股份有限公司 一种重组人酸性成纤维细胞生长因子凝胶剂及其制备工艺
CN116889545B (zh) * 2023-06-27 2023-12-29 上海腾瑞制药股份有限公司 一种重组人酸性成纤维细胞生长因子凝胶剂及其制备工艺

Also Published As

Publication number Publication date
WO2018232750A1 (zh) 2018-12-27
KR102480402B1 (ko) 2022-12-22
EP3643784A4 (en) 2021-05-05
JP7044870B2 (ja) 2022-03-30
EP3643784A1 (en) 2020-04-29
JP2020533015A (ja) 2020-11-19
US20200157164A1 (en) 2020-05-21
US11254723B2 (en) 2022-02-22
KR20200021521A (ko) 2020-02-28
SG11201912799SA (en) 2020-01-30
MY194351A (en) 2022-11-29

Similar Documents

Publication Publication Date Title
CN111315886A (zh) 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物
KR102236926B1 (ko) 안구 운반을 위한 키메릭 사이토카인 제제
US10071136B2 (en) Stable liquid formulations of recombinant fusion proteins
US10293045B2 (en) Stable liquid formulations of recombinant fusion proteins
KR20230066318A (ko) 재조합 변형된 섬유모세포 성장 인자 및 이의 치료적 용도
CN110945123B (zh) 生产可溶性重组人碱性成纤维细胞生长因子(rh-bFGF)的方法
KR20190137788A (ko) 안정한 펩타이드 조성물
JP2022548367A (ja) 眼科障害の処置または防止における使用のための薬剤
US10501511B2 (en) Low molecular polypeptide for preventing and treating inflammation and use thereof
WO2019237633A1 (zh) 含有重组人溶菌酶和重组人表皮生长因子的新型人工泪液
US20220088139A1 (en) Nerve growth factor mutant
RU2812055C1 (ru) Агент для использования при лечении или профилактике офтальмологических расстройств
CN104861058B (zh) 一类新的具有神经保护功能的多肽
WO2021120937A1 (zh) 转甲状腺素蛋白进入眼内以及在制备滴剂中的应用
US20230272023A1 (en) Ngf variants, production, compositions, and therapeutic uses
JP2023517459A (ja) 眼科用医薬組成物及びその使用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40031774

Country of ref document: HK